advertisement
Journal of Ocular Pharmacology and Therapeutics 28
Showing records 1 to 25 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Halkiadakis I
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334
61580 Secreted Protein Acidic and Rich in Cysteine in Ocular Tissue
Scavelli K
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 396-405
61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Ozkurt YB
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460
61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Prabhasawat P
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329
61306 Efficacy and Safety of Glaucoma Patients' Switch from a 2% Dorzolamide/0.5% Timolol Fixed-Combination Brand-Name Drug to Its Generic Counterpart
Kim YI
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 335-339
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Ruangvaravate N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329
61306 Efficacy and Safety of Glaucoma Patients' Switch from a 2% Dorzolamide/0.5% Timolol Fixed-Combination Brand-Name Drug to Its Generic Counterpart
Kim JH
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 335-339
60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Kontadakis GA
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334
61580 Secreted Protein Acidic and Rich in Cysteine in Ocular Tissue
Chatterjee A
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 396-405
61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Akkaya S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Adachi M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61306 Efficacy and Safety of Glaucoma Patients' Switch from a 2% Dorzolamide/0.5% Timolol Fixed-Combination Brand-Name Drug to Its Generic Counterpart
Lee TY
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 335-339
61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Aksoy S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460
60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Tsiakou D
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334
61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Tesavibul N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Hamada N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61580 Secreted Protein Acidic and Rich in Cysteine in Ocular Tissue
Rhee DJ
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 396-405
61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Thewthong M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329
61306 Efficacy and Safety of Glaucoma Patients' Switch from a 2% Dorzolamide/0.5% Timolol Fixed-Combination Brand-Name Drug to Its Generic Counterpart
Lee KW
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 335-339
60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Patsea E
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Honda N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Evciman T
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460
60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Mitropoulos P
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334
61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Haboğlu M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460
